Cooper D, Moisan J, Abdous B, Grégoire JP. A POPULATION-BASED COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE AND RISPERIDONE AMONG AMBULATORY PATIENTS WITH SCHIZOPHRENIA. J Popl Ther Clin Pharmacol. 2018;15(3). Accessed September 20, 2025. https://www.jptcp.com/index.php/jptcp/article/view/229